TA 4-SCC versus CEA sensitivity for lung cancer

F. Pecchio; M. Rapellino; E. Ricci; C. Casadio; D. Moscato; R. Adamo; L. Miserendino; F. Sansalvadore

doi:10.1177/030089168807400404

TA 4-SCC versus CEA sensitivity for lung cancer

F. Pecchio
, M. Rapellino
, E. Ricci
, C. Casadio
, D. Moscato
, R. Adamo
, L. Miserendino
, F. Sansalvadore

Research output: Contribution to journal › Article › peer-review

Abstract

The sensitivity of a new tumor marker, TA 4-SCC, for lung tumors is examined and compared with the performance of the already established CEA. TA 4-SCC sensitivity is only moderate (30%), and it presents no significant differences among the various histologic types of lung cancer. In addition, unlike CEA, TA 4-SCC is present in large amounts in the serum of many stage I and II patients. In fact, its sensitivity in still curatively operable tumors reaches 30% compared to 10% with CEA.

Original language	English
Pages (from-to)	393-395
Number of pages	3
Journal	Tumori
Volume	74
Issue number	4
DOIs	https://doi.org/10.1177/030089168807400404
Publication status	Published - 1988
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1177/030089168807400404

Cite this

@article{efbf38029e96478e8f9ffa6cca36ce50,

title = "TA 4-SCC versus CEA sensitivity for lung cancer",

abstract = "The sensitivity of a new tumor marker, TA 4-SCC, for lung tumors is examined and compared with the performance of the already established CEA. TA 4-SCC sensitivity is only moderate (30\%), and it presents no significant differences among the various histologic types of lung cancer. In addition, unlike CEA, TA 4-SCC is present in large amounts in the serum of many stage I and II patients. In fact, its sensitivity in still curatively operable tumors reaches 30\% compared to 10\% with CEA.",

author = "F. Pecchio and M. Rapellino and E. Ricci and C. Casadio and D. Moscato and R. Adamo and L. Miserendino and F. Sansalvadore",

year = "1988",

doi = "10.1177/030089168807400404",

language = "English",

volume = "74",

pages = "393--395",

journal = "Tumori",

issn = "0300-8916",

publisher = "Wichtig Publishing Srl",

number = "4",

}

TY - JOUR

T1 - TA 4-SCC versus CEA sensitivity for lung cancer

AU - Pecchio, F.

AU - Rapellino, M.

AU - Ricci, E.

AU - Casadio, C.

AU - Moscato, D.

AU - Adamo, R.

AU - Miserendino, L.

AU - Sansalvadore, F.

PY - 1988

Y1 - 1988

N2 - The sensitivity of a new tumor marker, TA 4-SCC, for lung tumors is examined and compared with the performance of the already established CEA. TA 4-SCC sensitivity is only moderate (30%), and it presents no significant differences among the various histologic types of lung cancer. In addition, unlike CEA, TA 4-SCC is present in large amounts in the serum of many stage I and II patients. In fact, its sensitivity in still curatively operable tumors reaches 30% compared to 10% with CEA.

AB - The sensitivity of a new tumor marker, TA 4-SCC, for lung tumors is examined and compared with the performance of the already established CEA. TA 4-SCC sensitivity is only moderate (30%), and it presents no significant differences among the various histologic types of lung cancer. In addition, unlike CEA, TA 4-SCC is present in large amounts in the serum of many stage I and II patients. In fact, its sensitivity in still curatively operable tumors reaches 30% compared to 10% with CEA.

UR - https://www.scopus.com/pages/publications/0023813250

U2 - 10.1177/030089168807400404

DO - 10.1177/030089168807400404

M3 - Article

SN - 0300-8916

VL - 74

SP - 393

EP - 395

JO - Tumori

JF - Tumori

IS - 4

ER -

TA 4-SCC versus CEA sensitivity for lung cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this